Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$848M |
| 2 |
Tesla
TSLA
|
+$759M |
| 3 |
Home Depot
HD
|
+$653M |
| 4 |
Meta Platforms (Facebook)
META
|
+$567M |
| 5 |
Wells Fargo
WFC
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$409M |
| 3 |
Micron Technology
MU
|
+$379M |
| 4 |
AT&T
T
|
+$372M |
| 5 |
Medtronic
MDT
|
+$370M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.69% |
| 2 | Technology | 14.95% |
| 3 | Consumer Discretionary | 11.34% |
| 4 | Consumer Staples | 10.7% |
| 5 | Communication Services | 8.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PARAA
2226
DELISTED
Paramount Global Class A
PARAA
| $2.03M | ﹤0.01% |
50,203
-106,951
| -68% | -$4M |
|
2227
AtaiBeckley Inc
ATAI
$2.66B
| $2.03M | ﹤0.01% |
398,242
+139,242
| +54% | +$774K |
|
2228
Pulmonx
LUNG
$85.3M
| $2.02M | ﹤0.01% |
81,600
-71,700
| -47% | -$1.85M |
|
2229
iShares MSCI Germany ETF
EWG
$1.61B
| $2.02M | ﹤0.01% |
+71,200
| New | +$2.17M |
|
2230
Donnelley Financial Solutions
DFIN
$1.2B
| $2.02M | ﹤0.01% |
60,700
+28,100
| +86% | +$1M |
|
2231
West Pharmaceutical
WST
$24.5B
| $2.01M | ﹤0.01% |
4,900
+3,300
| +206% | +$1.29M |
|
2232
Cracker Barrel
CBRL
$1.28B
| $2.01M | ﹤0.01% |
+16,932
| New | +$2.1M |
|
2233
Franklin Electric
FELE
$4.85B
| $2M | ﹤0.01% |
24,100
+18,800
| +355% | +$1.61M |
|
2234
AstroNova
ALOT
$227M
| $2M | ﹤0.01% |
131,742
-25,800
| -16% | -$363K |
|
2235
abrdn Physical Silver Shares ETF
SIVR
$4.16B
| $2M | ﹤0.01% |
83,800
+73,100
| +683% | +$1.69M |
|
2236
SoundThinking
SSTI
$106M
| $2M | ﹤0.01% |
72,032
+9,300
| +15% | +$253K |
|
2237
Traeger
COOK
$188M
| $1.99M | ﹤0.01% |
5,358
+3,746
| +232% | +$1.79M |
|
2238
KVH Industries
KVHI
$187M
| $1.99M | ﹤0.01% |
218,800
-46,586
| -18% | -$417K |
|
2239
ACM Research
ACMR
$5.75B
| $1.98M | ﹤0.01% |
95,800
-157,100
| -62% | -$3.95M |
|
|
CLSD
2240
DELISTED
Clearside Biomedical
CLSD
| $1.98M | ﹤0.01% |
57,663
+29,049
| +102% | +$869K |
|
2241
Corsair Gaming
CRSR
$1.21B
| $1.98M | ﹤0.01% |
93,600
+54,426
| +139% | +$1.14M |
|
|
ADAP
2242
DELISTED
Adaptimmune Therapeutics
ADAP
| $1.98M | ﹤0.01% |
959,703
+532,016
| +124% | +$1.44M |
|
|
TRT
2243
Trio-Tech International
TRT
$116M
| $1.97M | ﹤0.01% |
547,426
-53,848
| -9% | -$198K |
|
2244
Canadian Natural Resources
CNQ
$96.2B
| $1.97M | ﹤0.01% |
+64,936
| New | +$1.73M |
|
|
ESPR
2245
DELISTED
Esperion Therapeutics
ESPR
| $1.96M | ﹤0.01% |
+422,200
| New | +$1.81M |
|
|
ALYA
2246
DELISTED
Alithya Group Inc Class A Subordinate Voting Shares
ALYA
| $1.96M | ﹤0.01% |
756,232
-15,600
| -2% | -$41.9K |
|
2247
Aspen Aerogels
ASPN
$418M
| $1.96M | ﹤0.01% |
56,700
+22,549
| +66% | +$732K |
|
2248
Origin Bancorp
OBK
$1.71B
| $1.95M | ﹤0.01% |
46,100
+7,380
| +19% | +$323K |
|
|
SWAV
2249
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $1.95M | ﹤0.01% |
9,400
-43,100
| -82% | -$7.11M |
|
|
GBL
2250
DELISTED
GAMCO Investors, Inc.
GBL
| $1.95M | ﹤0.01% |
88,000
+2,500
| +3% | +$55.4K |
|
Similar funds
Renaissance Technologies's Q1 2022 Portfolio in Review
As of Q1 2022, Renaissance Technologies held 4,686 positions worth $85.2B, up 6% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies deployed $8.98B of net new capital in Q1 2022, opening 822 new positions and adding to 1,556 existing holdings. Its largest new stake was Advanced Micro Devices: 7,107,290 shares worth $777M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $409M trimmed.
- Renaissance Technologies's largest Q1 2022 buy was Advanced Micro Devices: 7,107,290 shares worth $777M.
- Renaissance Technologies added most to Tesla in Q1 2022, an estimated $759M increase.
- Renaissance Technologies's biggest Q1 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $409M.
- Renaissance Technologies fully exited Microsoft in Q1 2022, selling an estimated $786M.
- Renaissance Technologies's ten largest holdings make up 12% of its $85.2B portfolio in Q1 2022.
- Renaissance Technologies opened 822 new positions and closed 650 in Q1 2022.
- Renaissance Technologies's portfolio value rose 6% quarter-over-quarter to $85.2B.
Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.